L3VLUP
ProSign in

RPRX in the 13F filings

Royalty Pharma PLC · CUSIP G7709Q104

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 23 Jan 2026
Managers listing it
28
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 9 listed it in both
Shares listed
69,561,622
combined, among listed positions
Reported value
$2.7bn
combined, at the quarter end

Among the 92 comparable managers: 17 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,478,026.

Managers listing RPRX in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

28 of 28 holders

ActionFiling
Fidelity (FMR LLC)26,272,308$1.0bn0.05%Trimmed-1,714,40617 Feb 2026 (the filing on sec.gov)
Baillie Gifford & Co17,008,768$657m0.55%Trimmed-363,73423 Jan 2026 (the filing on sec.gov)
Citadel Advisors LLC5,273,865$204munder 0.1%Added+4,879,19217 Feb 2026 (the filing on sec.gov)
Jane Street Group LLC4,947,409$191munder 0.1%Added+1,795,74912 Feb 2026 (the filing on sec.gov)
Arrowstreet Capital LP3,313,265$128m0.07%Added+31,09113 Feb 2026 (the filing on sec.gov)
AQR Capital Management LLC2,563,654$99m0.05%Added+602,56817 Feb 2026 (the filing on sec.gov)
Squarepoint Ops LLC1,556,241$60m0.06%Added+870,45413 Feb 2026 (the filing on sec.gov)
Invesco Ltd1,502,171$58munder 0.1%Trimmed-87,34519 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc1,233,421$48munder 0.1%Added+202,63717 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP1,020,768$39munder 0.1%Added+83,91017 Feb 2026 (the filing on sec.gov)
Tudor Investment Corp924,819$36m0.07%Added+60,98417 Feb 2026 (the filing on sec.gov)
D. E. Shaw & Co.838,613$32munder 0.1%Added+698,58517 Feb 2026 (the filing on sec.gov)
Two Sigma Investments LP681,248$26munder 0.1%Trimmed-503,06317 Feb 2026 (the filing on sec.gov)
Point72 Asset Management LP534,306$21munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Two Sigma Advisers LP420,000$16munder 0.1%Trimmed-237,20017 Feb 2026 (the filing on sec.gov)
Marshall Wace LLP396,738$15munder 0.1%Trimmed-1,086,93813 Feb 2026 (the filing on sec.gov)
Man Group PLC388,162$15munder 0.1%Added+201,08017 Feb 2026 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC118,748$4.6munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Millennium Management LLC116,839$4.5munder 0.1%Trimmed-2,118,29417 Feb 2026 (the filing on sec.gov)
Quantbot Technologies LP104,056$4.0m0.13%Added+24,09510 Feb 2026 (the filing on sec.gov)
Voloridge Investment Management LLC100,528$3.9munder 0.1%Newnew17 Feb 2026 (the filing on sec.gov)
Verition Fund Management LLC95,068$3.7munder 0.1%Trimmed-206,00013 Feb 2026 (the filing on sec.gov)
Neuberger Berman Group LLC61,081$2.4munder 0.1%Added+19,43927 Oct 2026 (the filing on sec.gov)
Janus Henderson Group Ltd47,766$1.8munder 0.1%Added+14,37717 Feb 2026 (the filing on sec.gov)
Holocene Advisors LP17,380$672kunder 0.1%Trimmed-90817 Feb 2026 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (4)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
10 in Q3 2024 to 15 in Q2 2026

Tracked managers listing it, at least.

05101520202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
RPRX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 202010$1.8bnn.a.n.a.
Q3 20207$1.6bnn.a.n.a.
Q4 20205$1.9bnn.a.n.a.
Q1 20215$1.5bnn.a.n.a.
Q2 20218$1.5bnn.a.n.a.
Q3 20216$1.4bnn.a.n.a.
Q4 20218$1.8bnn.a.n.a.
Q1 20228$1.8bnn.a.n.a.
Q2 202210$3.2bnn.a.n.a.
Q3 202211$3.4bnn.a.n.a.
Q4 202217$3.4bnn.a.n.a.
Q1 202314$2.9bnn.a.n.a.
Q2 202316$2.3bnn.a.n.a.
Q3 202314$1.9bnn.a.n.a.
Q4 202313$2.1bn86
Q1 202410$2.2bn56
Q2 202412$1.7bn75
Q3 202410$2.0bn74
Q4 202410$1.6bn73
Q1 20259$2.3bn45
Q2 20259$2.4bn45
Q3 202511$1.9bn75
Q4 202510$2.4bn1714
Q1 202615$3.1bn1816
Q2 202615$3.9bn2117

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

RPRX and LLY →RPRX and JNJ →RPRX and VRTX →Choose a stock to compare with RPRX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own RPRX, latest filings →Back to the 13F Explorer →